From Genomes to Growth: Nadav Weinberg on Precision Medicine, Data, and Scaling Velsera

What if cancer treatment could be tailored not just to a diagnosis, but to you, your unique biology, history, and biomarkers?In this episode of Lightning RX, host Colette Nataf sits down with Nadav Weinberg, Chief Commercial Officer at Velsera, to explore how precision medicine is transforming healthcare. Velsera acts as the “connective tissue” of precision medicine, bridging labs, bioinformatics, and data ecosystems to enable personalized treatment for patients.Nadav shares insights from scaling multiple companies, including two unicorns and four successful exits, bringing his B2B SaaS growth expertise into the healthcare space. He breaks down:What You’ll Learn:How next-generation sequencing (NGS) data powers patient-specific treatments in oncologyWhy interoperability across labs, providers, and pharma is the missing piece in U.S. healthcareHow Velsera supports both lab pipelines and large-scale bioinformatic researchThe trust, compliance, and partnerships that helped secure early government contractsLessons on scaling from zero to one, building credibility, and setting the right culture in high-growth companiesWhy aligning product-market fit, customer trust, and scalable infrastructure is critical in healthtech💡 Golden Nugget: “Innovation is not just about the science, it’s about connecting the ecosystem, earning trust, and scaling responsibly.”Connect with Nadav Weinberg LinkedIn: linkedin.com/in/nadavweinbergConnect with the Show:LinkedInWebsiteSpotifyAmazon MusiciHeartSubscribe on Spotify, Apple Podcasts, or your favorite platform.If you enjoyed this episode, share it with someone passionate about healthcare marketing, startup growth, or innovative product launches, and don’t forget to leave us a review. New episodes drop weekly!